Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 17Unknown 7Terminated 4Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Genitourinary 1

Conditions

Small Cell Lung Carcinoma 23Lymphoma, Non-Hodgkin 18Leukemia, Myeloid, Acute 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lung Neoplasms 15Leukemia 13Carcinoma, Non-Small-Cell Lung 13Burkitt Lymphoma 13Recurrence 9Multiple Myeloma 9Lymphoma, Follicular 8Hodgkin Disease 8Leukemia, Lymphocytic, Chronic, B-Cell 7Congenital Abnormalities 7Lymphoma, B-Cell 6Sarcoma 5Neoplasms 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Neuroblastoma 4Neoplasms, Plasma Cell 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4

Interventions

Carboplatin 44Paclitaxel 43liposomal doxorubicin 23Topotecan 19Gemcitabine 18pembrolizumab 17Cyclophosphamide 17Bevacizumab 16Cisplatin 12niraparib 9olaparib 8fludarabine 7Taxes 7Docetaxel 7aldesleukin 6Nivolumab 6Doxorubicin 61-dodecylpyridoxal 6oregovomab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5rucaparib 4durvalumab 4avelumab 4Surgical Procedures, Operative 4Melphalan 4Ipilimumab 4Interleukin-2 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Ovarian Neoplasms × Etoposide × Clear all
NCT00003852 2016-06-23

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

UNICANCER

Phase 2 Terminated
45 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT00002478 2013-06-10

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

GOG Foundation

Phase 2 Terminated
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT00003380 2013-06-10

Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

GOG Foundation

Phase 1 Terminated
Gynecologic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00005612 2012-09-26

ETC

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Terminated
3 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡